{"id":"W2598547790","doi":"10.2196/resprot.7289","title":"Use of the Total Cancer Care System to Enrich Screening for CD30-Positive Solid Tumors for Patient Enrollment Into a Brentuximab Vedotin Clinical Trial: A Pilot Study to Evaluate Feasibility","year":2017,"lang":"en","type":"article","venue":"JMIR Research Protocols","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Cancer Institute; University of Louisville; Takeda Oncology; Virginia Commonwealth University; Moffitt Cancer Center; Quest Diagnostics","keywords":"Brentuximab vedotin; Medicine; Clinical trial; Oncology; Cancer; Medical physics; Internal medicine; CD30; Lymphoma","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01379283,0.0003922934,0.0004857775,0.0005980446,0.000746105,0.001064934,0.0005377736,0.0005593,0.004780798],"category_scores_gemma":[0.01243608,0.0002370661,0.0006997428,0.00082757,0.0006542242,0.0006677057,0.0009083222,0.0007363861,0.000702856],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001361985,"about_ca_system_score_gemma":0.004395188,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003107945,"about_ca_topic_score_gemma":0.003798836,"domain_scores_codex":[0.9934769,0.004891674,0.0003507006,0.000553685,0.000389158,0.0003379481],"domain_scores_gemma":[0.9849032,0.004681335,0.00368495,0.001764969,0.001735631,0.00322989],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1795451,0.01785668,0.7002384,0.0003069953,0.0004285432,0.0002868026,0.0007450547,0.001495661,0.00500611,0.0005972877,0.004769016,0.0887244],"study_design_scores_gemma":[0.0636174,0.1968392,0.7105483,0.0001062617,0.0009855803,0.000599648,0.000569812,0.01295242,0.004848287,0.0005518779,0.008297499,0.0000837212],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"protocol","genre_scores_codex":[0.9866111,0.0002487866,0.002539772,0.0003340126,0.00003586969,0.006838934,0.001368406,0.00008113736,0.001941966],"genre_scores_gemma":[0.9865242,0.0001096336,0.004688244,0.0004689498,0.000065148,0.006435142,0.001289719,0.00001704505,0.0004018887],"genre_candidate":"protocol","genre_consensus":null,"teacher_disagreement_score":0.01379283,"threshold_uncertainty_score":0.07294434,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.6744726766871684,"score_gpt":0.6790201270023464,"score_spread":0.004547450315178003,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}